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Objectives: This study was performed to examine the cause of the increase in quinolone-resistant
Neisseria gonorrhoeae (QRNG) observed in Korea.
Methods: The antimicrobial susceptibilities of 190 isolates of gonococci from Korea in 2000 were exam-
ined by NCCLS methods, and subsets of these isolates underwent mutation analysis of the quinolone
resistance-determining regions (QRDRs) of gyrA and parC. Molecular epidemiological characterization
of 25 Korean isolates and 54 isolates from overseas was performed by pulsed-field gel electrophoresis
(PFGE) and the results compared.
Results: Most (172, 90.5%) of the 190 gonococci tested displayed reduced susceptibility to ciprofloxa-
cin. All strains with high-level ciprofloxacin resistance (ciprofloxacin MIC >_ 4 mg/L) contained a double
amino acid alteration at the 91 and 95 positions in the QRDR of GyrA and a single alteration in ParC.
PFGE types of high-level QRNG in Korea were mostly different from those of other nearby countries.
Conclusions: These results suggest that the observed increase in ciprofloxacin-resistant isolates is
due to the mutation and spread of Korean multiclonal isolates rather than importation from overseas.
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Introduction
Neisseria gonorrhoeae is the causative agent of gonorrhoea, one
of the most commonly reported sexually transmitted diseases
worldwide. The emergence of resistance to antimicrobial agents
in gonococci has complicated its treatment and control.1 How-
ever, the prevalence of antimicrobial resistance varies greatly
between countries.2
In recent years, a decrease in the proportion of penicillinase-
producing N. gonorrhoeae (PPNG) and a rapid increase in qui-
nolone-resistant N. gonorrhoeae (QRNG) have been reported to
be related in some countries.3 – 5 However, in Korea, the pro-
portion of PPNG has remained high (84%), and strains with
reduced susceptibility to ciprofloxacin increased rapidly from
9% in 1992 to 84% in 1999.6,7 This phenomenon may be
caused by the spread of strains in which the gyrA and parC
mutations arose locally or by the importation of QRNG from
overseas followed by sustained domestic transmission of resist-
ant subtypes. In either case, the QRNG may be of multiple sub-
types or else represent the expansion of limited numbers of
subtypes.
The aims of this study were to examine the cause of the
increase in QRNG observed in Korea by testing antimicrobial
susceptibility, analysing the mutations of the quinolone resist-
ance-determining regions (QRDRs) of gyrA and parC of fluoro-
quinolone-non-susceptible isolates, and comparing the molecular
epidemiological characteristics of QRNG in Korea with those of
other nearby countries.
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Materials and methods
N. gonorrhoeae isolates
One hundred and ninety gonococci were isolated from Korean
patients or prostitutes attending sexually transmitted diseases clinics
in Seoul in 2000 using modified Thayer-Martin agar (BBL, Becton
Dickinson, Cockeysville, MD, USA). Species identification was
based on conventional culture and biochemical characteristics.8 The
isolates were kept frozen at 708C until used.
For comparison purposes, 54 random gonococcal isolates from
patients infected in nearby countries, namely, Australia, China,
Mongolia, the Philippines, India, Malaysia, Singapore, Thailand,
Vanuatu and Vietnam from 1995 to 2000, were obtained from the
regional World Health Organization (WHO) reference laboratory in
Sydney, Australia.
Antimicrobial susceptibility testing
The medium used for susceptibility testing was GC II agar base sup-
plemented with 1% IsoVitaleX (Becton Dickinson). All 190 Korean
isolates were initially examined by the disc diffusion testing methods
of the NCCLS9 using a 5mg ciprofloxacin disc (Becton Dickinson).
Forty-nine Korean gonococcal strains isolated consecutively
between April and June 2000, and the 54 gonococci from nearby
countries were examined for susceptibility by the NCCLS agar
dilution method.10 Seventeen of 20 isolates with no ciprofloxacin
inhibition zone among 190 isolates were tested by the agar dilution
test to determine the level of ciprofloxacin resistance. Ciprofloxacin
powder was supplied by Bayer Korea (Seoul, Korea). Inocula of
 104 cfu were applied using a Steers replicator (Craft Machine,
Chester, PA, USA). Plates were incubated in a 5% CO2 incubator at
358C for 24 h after which the results were read. Strains with high-
level ciprofloxacin resistance were defined as those for which the
MIC was >_4 mg/L.11 N. gonorrhoeae ATCC 49226 was used as a
control strain. During 2000 and 2001, our laboratory accurately cate-
gorized those QRNG included in an external quality assurance pro-
gramme conducted by the WHO Western Pacific Region
Gonococcal Antimicrobial Surveillance Programme (GASP).12
Sequencing the QRDRs of gyrA and parC
Twenty-nine Korean gonococcal isolates with various ciprofloxacin
disc susceptibility patterns were randomly selected, and the cipro-
floxacin MICs for these isolates were also determined by the agar
dilution method. The QRDRs of these isolates were investigated by
sequencing and these results were correlated with the MICs of
ciprofloxacin. The QRDR sequences of the gyrA and parC genes
were amplified using PCR primers as reported by Tanaka et al.3
PCR was carried out with 1mL of heat-extracted template DNA,
10 pmol of each primer and PreMix (Bioneer, Cheongwon, Korea)
containing 1 U of Taq DNA polymerase in a total volume of 20mL.
A thermal cycler (Eppendorf, Hamburg, Germany) was used under
the following conditions: 35 cycles of 938C for 30 s, 588C for 30 s
and 728C for 1 min. The PCR products were extracted using a DNA
extraction kit (Qiagen, Hilden, Germany), and their nucleotide
sequences were determined by the dideoxynucleotide-chain termi-
nation method with ABI PRISM BigDye Terminator Sequencing
Kits (Perkin-Elmer, Foster City, CA, USA) and using an automatic
DNA sequencer (ABI 3700; Perkin-Elmer).
Epidemiological study
Pulsed-field gel electrophoresis (PFGE) was performed on a total of
79 strains for which the ciprofloxacin MICs were determined by
agar dilution methods, namely, 25 of the 29 randomly selected iso-
lates from Korea, and the 54 gonococci from overseas, as described
previously.7 Briefly, the plugs were prepared by using saline EDTA
solution-suspended cells cultured overnight. The genomic DNA
was digested with Nhe I (Takara, Tokyo, Japan) for 18 h at 358C.
The CHEF DR II instrument (Bio-Rad, Hercules, CA, USA) was
used to separate the fragments, with switch times of 0.5 s (initial)
and 54 s (final), and a running time of 20 h at 6 V/cm. PFGE band-
ing pattern similarities were determined using the Dice coefficients
and unweighted pair group method using arithmetic averages
(UPGMA) clustering method using Molecular Analyst Fingerprint-
ing Software (v. 1.12; Bio-Rad). A tolerance in the band positions
of 0.5% was used. An 80% similarity threshold was used to divide
the outputs from the dendrogram into clusters.
Results
Antimicrobial susceptibility
Ciprofloxacin disc susceptibilities of the 190 isolates were: 18
(9.5%) susceptible, 122 (64.2%) intermediate and 50 (26.3%)
resistant. For the 17 isolates with no ciprofloxacin inhibition
zone, ciprofloxacin MICs were >_16 mg/L (data not shown). The
susceptibilities of the 49 Korean and the 54 non-Korean isolates,
as determined by agar dilution methods, are shown in Table 1.
The MIC range of ciprofloxacin for N. gonorrhoeae was
<_0.015–32 mg/L, and the geometric mean ciprofloxacin MIC
was 0.396 mg/L. The ciprofloxacin susceptibility categories of
the 54 overseas isolates were: eight susceptible, 12 intermediate
and 34 resistant. Among these isolates, 22 (40.7%) were high-
level ciprofloxacin resistant with MICs of >_4 mg/L.
Table 1. Ciprofloxacin susceptibility of 49 Korean and 54 non-Korean N. gonorrhoeae isolates tested by the agar dilution method
No. of isolates with MIC (mg/L) MIC (mg/L)
Percentage
of isolates
Source of isolates
(no. of isolates tested) <_0.015 0.03 0.06 0.12 0.25 0.5 1 2 4 8 16 32 50% 90%
geometric
mean S I R
Korea (49) 4 4 6 32 3 0.5 0.5 0.396 8 86 6
Nearby countries (54) 2 2 4 3 3 6 6 6 12 5 5 2 16 1.071 19 18 63
S, susceptible; I, intermediate; R, resistant.
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Genetic alterations in the QRDRs
The ciprofloxacin MICs for 29 randomly selected Korean iso-
lates are shown in Table 2 together with details of the QRDR
alterations present. All 17 of the high-level ciprofloxacin-
resistant Korean isolates contained three amino acid substi-
tutions in the GyrA and ParC proteins. Of these, the most
common substitutions (in 16 of 17 strains) were serine to
phenylalanine at position 91 and aspartic acid to glycine at pos-
ition 95 in GyrA, and serine to arginine at position 87 in ParC.
The isolates for which ciprofloxacin MICs were 0.12–2 mg/L
contained one or two amino acid substitutions in GyrA alone.
No alterations in GyrA and ParC were detected in the three
susceptible strains.
Molecular types of the Korean and overseas strains
Among the 25 Korean isolates examined, 13 PFGE types were
observed: eight strains (32.0%) were E type and four (16.0%) a
type (Figure 1). In contrast, 33 PFGE types were observed
among the 54 overseas isolates: five strains (9.3%) were Q type
and four (7.4%) showed b and g types.
The 13 Korean isolates with high-level ciprofloxacin resist-
ance were of the E1 (four strains), E2 (four), a (four) or W2
(one) PFGE type, while the 22 overseas isolates belonged to b
type (four strains), K type (two), e type (two), k2 type (two)
and several other types (12). One ciprofloxacin-susceptible
Korean isolate was of the W1 type, which resembled the W2
type of a high-level ciprofloxacin-resistant strain. K, k2 and
n types were shown by four ciprofloxacin-susceptible Korean
isolates and five ciprofloxacin-susceptible or -resistant overseas
isolates.
Discussion
N. gonorrhoeae strains with high-level ciprofloxacin resistance
(MICs of >_4 mg/L) have been reported in several countries.11,13
In our previous studies,6,7 all isolates were inhibited by <_1 mg/L
of ciprofloxacin. In the present study, 20 of 190 isolates in
2000 showed no ciprofloxacin inhibition zone. These isolates
were tested by agar dilution test and showed that they were
highly resistant to ciprofloxacin, with MICs of >_16 mg/L (Tables
1 and 2). Also, the MIC50 for strains isolated in 2000 was
0.5 mg/L, which was 4- to 32-fold higher than those found in
our previous studies in 1993 and 1996.6
Generally, gyrA mutations play an important role in the
development of fluoroquinolone resistance in gonococci, and
simultaneous parC mutations play a complementary role in
increasing the level of resistance.14,15 Shultz et al.11 also reported
that the sequence and nature of the QRDR changes were found
to correlate with MICs of ciprofloxacin, and some parC altera-
tions do not have a significant effect on MIC. In this study, we
found that all strains with high-level ciprofloxacin-resistance
contained a double amino acid alteration at the 91 and 95 posi-
tions in the QRDR of GyrA and a single alteration in ParC.
These findings concur with those of other investigators.14,15 How-
ever, the amino acid substitutions in Korean isolates with high-
level ciprofloxacin resistance were of a similar configuration in
16 of 17 instances, suggesting that ‘clonal’ expansion of a
QRNG may have been involved. The amino acid substitutions in
the predominant QRDR change seen differed from those
reported by some other investigators in the region,3,13,15 although
they were also observed in a QRNG isolated from an infection
acquired in China.11
One of the aims of this study was to determine whether the
increase in high-level ciprofloxacin-resistant N. gonorrhoeae
observed in Korea was caused by the importation of resistant
strains from overseas, or by the spread of resistant variants,
perhaps selected by antibiotic pressures in Korea.
N. gonorrhoeae strains are genetically diverse due to the fre-
quent transfer and recombination of genetic elements between
strains.16 Su & Lind15 reported that a common epidemic ‘clone’
might be widely spread in the Philippines, Hong Kong,
Romania, New Guinea and Denmark, but the study was based
on examination of small numbers of ciprofloxacin-resistant
isolates. In contrast, Trees et al.13 reported that ciprofloxacin-
resistant isolates in Bangkok were not from a single ‘clonal’
source, but of diverse subtypes from multiple cases of importa-
tion or local emergence.
Among the 25 Korean isolates examined, 13 PFGE types
were found (Figure 1). Of these, 13 isolates were high-level
ciprofloxacin resistant and all had the same QRDR changes.
Eight of the 13 high-level ciprofloxacin-resistant strains were of
the E type, indicating a significant degree of strain relatedness.
However, the other five high-level resistant strains with the same
QRDR alterations were from unrelated PFGE types (four a and
one W2). One high-level ciprofloxacin-resistant W2-type Korean
isolate was closely related to a ciprofloxacin-susceptible
W1-type Korean isolate. The PFGE patterns of the high-level
ciprofloxacin-resistant strains from Korea differed from those of
isolates in other nearby countries. It is tempting to suggest from
these results that the observed increase in high-level ciprofloxa-
cin-resistant strains in Korea may have arisen as a result of the
spread of multiclonal resistant variants of domestic strains. In
this circumstance, the predominant QRDR change observed
could have arisen locally and spread amongst already circulating
strains. This phenomenon has been observed in a study of a
closed population in Mongolia.17 Among the isolates with K, k2
and n types in this study, all Korean isolates were ciprofloxacin-
susceptible, while some non-Korean isolates were ciprofloxacin-
resistant, suggesting that the resistance was not introduced from
overseas.
Table 2. Amino acid substitutions within GyrA and ParC in 29
randomly selected Korean isolates of N. gonorrhoeaea
GyrA ParC
Ciprofloxacin MIC (mg/L) No. Ser-91 Asp-95 Gly-85 Ser-87
16–64 16 Phe Gly – Arg
1 Phe Asn Cys –
2 1 Phe Gly – –
0.25–0.5 5 Phe – – –
1 Phe Gly – –
0.12 1 – Gly – –
1 – Asn – –
<_0.008 3 – – – –
A dash indicates sequence homology.
aThe numbering of the amino acids of GyrA and ParC proteins is from Gen-
Bank accession numbers U08817 and U08907, respectively.
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Figure 1. Dendrogram of PFGE band pattern of strains from Korea and nearby countries. The band differences of Nhe I-digested genomic DNAs of 79 strains
of N. gonorrhoeae (25 isolated in Korea and 54 in other countries) were analysed using the Dice coefficients and unweighted pair group method using arith-
metic averages (UPGMA) clustering method using Molecular Analyst Fingerprinting Software. Bold type indicates strains with high-level ciprofloxacin resist-
ance (MIC >_ 4 mg/L).
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